Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer (Q34347197)

1 August 2017

1 reference

title

Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer (English)

1 reference

1 August 2017

Riccardo Sgarra

1

0 references

Alfredo Fusco

object named as

Alfredo Fusco

6

0 references

author name string

Alessandra Rustighi

2

1 reference

1 August 2017

Michela A Tessari

3

1 reference

1 August 2017

Julie Di Bernardo

4

1 reference

1 August 2017

Sandro Altamura

5

1 reference

1 August 2017

Guidalberto Manfioletti

7

1 reference

1 August 2017

Vincenzo Giancotti

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

1 August 2017

1 reference

1 August 2017

574

1 reference

1 August 2017

1-3

1 reference

1 August 2017

1-8

1 reference

Fractionation by high-performance liquid chromatography of the low-molecular-mass high-mobility-group (HMG) chromosomal proteins present in proliferating rat cells and an investigation of the HMG proteins present in virus transformed cells.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Molecular biology of HMGA proteins: hubs of nuclear function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

A small region in HMG I(Y) is critical for cooperation with NF-kappaB on DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Coordination of a transcriptional switch by HMGI(Y) acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

PU.1-mediated transcription is enhanced by HMG-I(Y)-dependent structural mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

In vivo modulation of Hmgic reduces obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

RETRACTED: Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Hmga1 is required for normal sperm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Expression of the HMGI(Y) gene in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

HMG-I/Y, a new c-Myc target gene and potential oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Role of the high mobility group A proteins in human lipomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Increase of HMGA1a protein methylation is a distinctive characteristic of leukaemic cells induced to undergo apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Interleukin 4-inducible phosphorylation of HMG-I(Y) is inhibited by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Cdc2 and mitogen-activated protein kinases modulate DNA binding properties of the putative transcriptional regulator Chironomus high mobility group protein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Molecular dissection of the architectural transcription factor HMGA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Architecture of high mobility group protein I-C.DNA complex and its perturbation upon phosphorylation by Cdc2 kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

DNA methylation and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Histone methylation versus histone acetylation: new insights into epigenetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.08.013

Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1128/MCB.15.3.1545

A new antitumor antibiotic, FR-900482. I. Taxonomic studies on the producing strain: a new species of the genus Streptomyces.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.40.589

Identifiers

DOI

10.1016/J.FEBSLET.2004.08.013

1 reference

1 August 2017

1 reference